NCOA3 and breast neoplasm: Using a syngeneic mouse model of breast cancer, here, we found that SRC-3 inhibition by SI-2 treatment and SRC-3 knockdown generated tumor-suppressing TIME by recruiting cytotoxic immune cells changing through Cxcl9 elevation in breast tumors to aid in the suppression of breast tumor progression.